Tearsheet
Investment Highlights Market Valuation Price Chart About KMB Interactive Breakdown Better Bets vs. KMB Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Kimberly-Clark (KMB)

Market Price (10/15/2025): $120.28 | Market Cap: $39.9 Bil
Sector: Consumer Staples | Industry: Household Products

Kimberly-Clark (KMB)

Market Price (10/15/2025): $120.28
Market Cap: $39.9 Bil
Sector: Consumer Staples
Industry: Household Products

Investment Highlights

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 10%, Dividend Yield is 4.1%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 5.8%, FCF Yield is 5.3%		 Weak multi-year price returns
2Y Excs Rtn is -44%, 3Y Excs Rtn is -60%		 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -3.1%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -2.1%, Rev Chg QQuarterly Revenue Change % is -1.6%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 11%, CFO LTM is 2.9 Bil, FCF LTM is 2.1 Bil		  
2 Low stock price volatility
Vol 12M is 19%		  
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 10%, Dividend Yield is 4.1%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 5.8%, FCF Yield is 5.3%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 11%, CFO LTM is 2.9 Bil, FCF LTM is 2.1 Bil
2 Low stock price volatility
Vol 12M is 19%
3 Weak multi-year price returns
2Y Excs Rtn is -44%, 3Y Excs Rtn is -60%
4 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -3.1%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -2.1%, Rev Chg QQuarterly Revenue Change % is -1.6%

Market Valuation & Key Metrics

KMBS&P 500
REVENUE GROWTHVERY POOR
Rev LTM ($ Bil)18.9
Rev Chg Q-1.6%6.1%
Rev Chg LTM-3.1%5.2%
Rev Chg 3Y Avg-2.1%5.3%
PROFITABILITYFAIR
Op Inc LTM ($ Bil)3.2
Op Mgn LTM16.7%18.6%
CFO LTM ($ Bil)2.9
CFO/Rev LTM15.2%20.3%
Net Inc LTM ($ Bil)2.4
Net Inc Mgn12.9%12.7%
VALUATIONMODERATE
P/S2.13.2
P/CFO13.915.7
P/FCF19.020.6
P/E16.423.6
STABILITYGOOD
Debt/Equity0.180.21
Cash/Assets0.040.07

KMB Stock

Factor Drivers of Stock Movement
The -13.4% change in KMB stock from 4/15/2025 to 10/14/2025 was primarily driven by a -9.5% change in the company's P/E Multiple.

415202510142025Change
Stock Price ($)138.79120.17-13.41%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)19260.0018883.00-1.96%
Net Income Margin (%)13.21%12.87%-2.61%
P/E Multiple18.1416.42-9.45%
Shares Outstanding (Mil)332.60332.100.15%
Cumulative Contribution-13.41%

LTM = Last Twelve Months as of date shown
The -13.1% change in KMB stock from 10/14/2024 to 10/14/2025 was primarily driven by a -19.5% change in the company's P/E Multiple.

1014202410142025Change
Stock Price ($)138.34120.17-13.13%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)19482.0018883.00-3.07%
Net Income Margin (%)11.74%12.87%9.62%
P/E Multiple20.3916.42-19.46%
Shares Outstanding (Mil)337.10332.101.48%
Cumulative Contribution-13.15%

LTM = Last Twelve Months as of date shown
The 18.5% change in KMB stock from 10/15/2022 to 10/14/2025 was primarily driven by a 45.1% change in the company's Net Income Margin (%).

1015202210142025Change
Stock Price ($)101.43120.1718.48%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)20133.0018883.00-6.21%
Net Income Margin (%)8.87%12.87%45.06%
P/E Multiple19.1616.42-14.29%
Shares Outstanding (Mil)337.40332.101.57%
Cumulative Contribution18.45%

LTM = Last Twelve Months as of date shown

Price Returns Compared

 202020212022202320242025Total [1]
Returns
KMB Return1%10%-2%-7%12%-6%6%
Peers Return17%9%-6%3%12%2%41%
S&P 500 Return16%27%-19%24%23%13%103%

Monthly Win Rates [3]
KMB Win Rate58%50%42%33%50%44% 
Peers Win Rate57%50%45%53%65%47% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
KMB Max Drawdown-18%-5%-21%-11%-3%-6% 
Peers Max Drawdown-18%-10%-19%-9%-2%-9% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: JNJ, PG, UL, CL, CHD. See KMB Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/14/2025 (YTD)

Downturns Compared

Unique KeyEventKMBS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-23.6%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven30.9%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven200 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-24.2%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven32.0%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven127 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-27.0%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven37.0%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven415 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-39.7%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven65.8%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven947 days1480 days


How Low Can It Go?

Kimberly-Clark's stock fell -23.6% during the 2022 Inflation Shock from a high on 4/25/2022. A -23.6% loss requires a 30.9% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Kimberly-Clark (KMB)

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Interactive Breakdown

Kimberly-Clark Interactive Breakdown Analysis

Better Bets than Kimberly-Clark (KMB)

 KMBBetter Performance than KMB
MetricValueIndustry (Household Products)
Rev Chg LTM-3.1%UL (11.1%), CL (0.1%), CHD (1.1%), CLX (0.2%), IPAR (7.0%)
Rev Chg 3Y Avg-2.1%UL (3.4%), CL (4.2%), CHD (4.6%), CLX (0.0%), IPAR (14.9%)
Op Mgn LTM16.7%CL (21.7%), CHD (17.8%), IPAR (19.2%), EWCZ (22.1%), UG (25.9%)
CFO/Rev LTM15.2%CL (19.6%), CHD (17.7%), EWCZ (27.9%), UG (19.6%)
FCF/Rev LTM11.1%UL (12.4%), CL (16.9%), CHD (15.3%), WDFC (13.3%), EWCZ (27.1%)
Total Yield10.2%ENR (20.0%), NUS (21.5%), UG (16.8%)
 KMBBetter Performance than KMB
MetricValueAll Other Sectors
Rev Chg LTM-3.1%NVDA (71.6%), MSFT (14.9%), AAPL (6.0%), GOOGL (13.1%), AMZN (10.9%)
Rev Chg 3Y Avg-2.1%NVDA (92.0%), MSFT (12.5%), AAPL (1.8%), GOOGL (10.2%), AMZN (11.3%)
Op Mgn LTM16.7%NVDA (58.1%), MSFT (45.6%), AAPL (31.9%), GOOGL (32.7%), META (42.9%)
CFO/Rev LTM15.2%NVDA (46.6%), MSFT (48.3%), AAPL (26.6%), GOOGL (36.0%), AMZN (18.1%)
FCF/Rev LTM11.1%NVDA (43.6%), MSFT (25.4%), AAPL (23.5%), GOOGL (18.0%), META (30.7%)
Total Yield10.2%BABA (38.7%), TM (2181.5%), MRK (11.5%), VZ (17.3%), PFE (12.9%)

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1Why CLX, IPAR May Be Better Than Kimberly-Clark StockActionable 
2Kimberly-Clark Earnings Notes  
3Kimberly-Clark vs Merck: Which Is A Better Investment?Counter-Intuitive Comparisons 
4Kimberly-Clark vs Keurig Dr Pepper: Which Is A Better Investment?Counter-Intuitive Comparisons 
5Kimberly-Clark vs Clorox: Which Is A Better Investment?Counter-Intuitive Comparisons 
6Better Bet Than KMB Stock: Pay Less Than Kimberly-Clark To Get More From PPC, SJM   
7Kimberly-Clark Total Shareholder Return (TSR): 15.7% in 2024 and 4.6% 3-yr compounded annual returns (below peer average)  
8Why Kimberly-Clark Stock Moved: KMB Stock Has Lost 6% Since 2024 Fiscal End, Primarily Due To Unfavorable Change In Revenues  
9Kimberly-Clark (KMB) Operating Cash Flow ComparisonFinancials 
10Kimberly-Clark (KMB) Net Income ComparisonFinancials 
11ARTICLES  
12S&P 500 Stocks Trading At 52-Week Low October 10th, 2025
13S&P 500 Stocks Trading At 52-Week Low October 9th, 2025
14S&P 500 Stocks Trading At 52-Week Low October 7th, 2025
15Better Bet Than Kimberly-Clark Stock: Pay Less To Get More From CLX October 2nd, 2025
16Better Bet Than Kimberly-Clark Stock: Pay Less To Get More From CLX August 30th, 2025
Title
0DASHBOARDS
1S&P 500 Stocks Trading At 52-Week Low
2S&P 500 Stocks Trading At 52-Week Low
3S&P 500 Stocks Trading At 52-Week Low
4Better Bet Than Kimberly-Clark Stock: Pay Less To Get More From CLX
5Better Bet Than Kimberly-Clark Stock: Pay Less To Get More From CLX
6ARTICLES
7Why CLX, IPAR May Be Better Than Kimberly-Clark Stock
8Kimberly-Clark Earnings Notes
9Kimberly-Clark vs Merck: Which Is A Better Investment?
10Kimberly-Clark vs Keurig Dr Pepper: Which Is A Better Investment?
11Kimberly-Clark vs Clorox: Which Is A Better Investment?
12Better Bet Than KMB Stock: Pay Less Than Kimberly-Clark To Get More From PPC, SJM 
13Kimberly-Clark Total Shareholder Return (TSR): 15.7% in 2024 and 4.6% 3-yr compounded annual returns (below peer average)
14Why Kimberly-Clark Stock Moved: KMB Stock Has Lost 6% Since 2024 Fiscal End, Primarily Due To Unfavorable Change In Revenues
15Kimberly-Clark (KMB) Operating Cash Flow Comparison
16Kimberly-Clark (KMB) Net Income Comparison

Trade Ideas

Select past trade ideas related to KMB and Household Products.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
IPAR_9302025_Dip_Buyer_FCFYield09302025IPARInterparfumsDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-4.6%-4.6%-6.0%
TAP_9302025_Dip_Buyer_FCFYield09302025TAPMolson Coors BeverageDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		3.3%3.3%0.0%
STZ_7312025_Monopoly_xInd_xCD_Getting_Cheaper07312025STZConstellation BrandsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-15.4%-15.4%-21.1%
SJM_6302025_Dip_Buyer_FCFYield06302025SJMJM SmuckerDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		5.3%5.3%0.0%
BF-B_5312025_Dip_Buyer_ValueBuy05312025BF-BBrown-FormanDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		-16.1%-16.1%-22.4%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
IPAR_9302025_Dip_Buyer_FCFYield09302025IPARInterparfumsDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-4.6%-4.6%-6.0%
TAP_9302025_Dip_Buyer_FCFYield09302025TAPMolson Coors BeverageDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		3.3%3.3%0.0%
STZ_7312025_Monopoly_xInd_xCD_Getting_Cheaper07312025STZConstellation BrandsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-15.4%-15.4%-21.1%
SJM_6302025_Dip_Buyer_FCFYield06302025SJMJM SmuckerDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		5.3%5.3%0.0%
BF-B_5312025_Dip_Buyer_ValueBuy05312025BF-BBrown-FormanDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		-16.1%-16.1%-22.4%

See Trefis Trade Ideas for more.

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1UAMYUnited States Antimony100.8%887.0%
2BITFBitfarms69.7%295.3%
3NVTSNavitas Semiconductor61.6%252.1%
4ASPIASP Isotopes58.0%210.2%
5UUUUEnergy Fuels49.1%411.3%
6GLUEMonte Rosa Therapeutics43.8%52.9%
7SSIISS Innovations International34.1%15.2%
8METCRamaco Resources34.0%439.5%
9MPMP Materials33.7%532.4%
10ORKAOruka Therapeutics33.6%41.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1BNTBrookfield Wealth Solutions-33.2%18.5%
2BNBrookfield-33.0%18.9%
3VGVenture Global-30.2% 
4ALABAstera Labs-23.8%22.0%
5HELEHelen Of Troy-23.3%-65.4%
6CORTCorcept Therapeutics-20.2%43.1%
7USNAUsana Health Sciences-19.4%-40.9%
8SRRKScholar Rock-19.2%-26.2%
9TASKTaskUs-18.8%-18.1%
10BBBYBed Bath & Beyond-18.1% 

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1WOLFWolfspeed1000.7%389.2%
2QUREuniQure297.4%233.9%
3UAMYUnited States Antimony244.6%887.0%
4LACLithium Americas214.1%238.4%
5RGTIRigetti Computing192.1%267.8%
6USARUSA Rare Earth173.3%125889.9%
7PLUGPlug Power158.0%90.1%
8FLNCFluence Energy149.7%16.2%
9CLPTClearPoint Neuro148.6%69.2%
10SESSES AI140.2%44.7%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1ANGXAngel Studios-53.8% 
2REXREX American Resources-46.2%57.7%
3VGVenture Global-34.0% 
4LDIloanDepot-33.8%46.6%
5FLYFirefly Aerospace-31.4% 
6ALABAstera Labs-30.2%22.0%
7FWRDForward Air-29.4%-34.3%
8USNAUsana Health Sciences-29.1%-40.9%
9IDTIDT-28.9%-0.4%
10PGYPagaya Technologies-28.8%221.4%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1UAMYUnited States Antimony100.8%887.0%
2BITFBitfarms69.7%295.3%
3NVTSNavitas Semiconductor61.6%252.1%
4ASPIASP Isotopes58.0%210.2%
5UUUUEnergy Fuels49.1%411.3%
6GLUEMonte Rosa Therapeutics43.8%52.9%
7SSIISS Innovations International34.1%15.2%
8METCRamaco Resources34.0%439.5%
9MPMP Materials33.7%532.4%
10ORKAOruka Therapeutics33.6%41.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1BNTBrookfield Wealth Solutions-33.2%18.5%
2BNBrookfield-33.0%18.9%
3VGVenture Global-30.2% 
4ALABAstera Labs-23.8%22.0%
5HELEHelen Of Troy-23.3%-65.4%
6CORTCorcept Therapeutics-20.2%43.1%
7USNAUsana Health Sciences-19.4%-40.9%
8SRRKScholar Rock-19.2%-26.2%
9TASKTaskUs-18.8%-18.1%
10BBBYBed Bath & Beyond-18.1% 

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Kimberly-Clark

Financials

KMBJNJPGULCLCHDMedian
NameKimberly.Johnson .Procter .Unilever Colgate-.Church &. 
Mkt Price120.17190.85149.1660.9978.4086.93103.55
Mkt Cap39.9459.2349.8171.663.521.3117.5
Rev LTM18,88390,62784,28444,26219,9996,06632,130
Op Inc LTM3,16022,22820,4506,3594,3461,0795,352
FCF LTM2,10216,39714,0445,4903,3709314,430
FCF 3Y Avg2,45616,92614,7854,8063,0288653,917
CFO LTM2,87223,02817,8175,4903,9201,0734,705
CFO 3Y Avg3,22122,24818,1705,0453,6591,0594,352

Growth & Margins

KMBJNJPGULCLCHDMedian
NameKimberly.Johnson .Procter .Unilever Colgate-.Church &. 
Rev Chg LTM-3.1%4.7%0.3%11.1%0.1%1.1%0.7%
Rev Chg 3Y Avg-2.1%4.0%1.7%3.4%4.2%4.6%3.7%
Rev Chg Q-1.6%5.8%1.7%12.0%1.0%-0.3%1.4%
QoQ Delta Rev Chg LTM-0.4%1.5%0.4%2.7%0.3%-0.1%0.3%
Op Mgn LTM16.7%24.5%24.3%14.4%21.7%17.8%19.8%
Op Mgn 3Y Avg15.2%26.3%23.3%7.9%21.2%18.3%19.8%
QoQ Delta Op Mgn LTM0.3%-0.2%0.5%-4.5%-0.1%-1.2%-0.2%
CFO/Rev LTM15.2%25.4%21.1%12.4%19.6%17.7%18.6%
CFO/Rev 3Y Avg16.5%25.7%21.8%12.2%18.7%18.0%18.3%
FCF/Rev LTM11.1%18.1%16.7%12.4%16.9%15.3%16.0%
FCF/Rev 3Y Avg12.5%19.6%17.7%11.6%15.4%14.7%15.1%

Valuation

KMBJNJPGULCLCHDMedian
NameKimberly.Johnson .Procter .Unilever Colgate-.Church &. 
Mkt Cap39.9459.2349.8171.663.521.3117.5
P/S2.15.14.23.93.23.53.7
P/EBIT13.116.316.626.015.127.316.4
P/E16.420.321.940.421.840.521.9
P/CFO13.919.919.631.216.219.819.7
Total Yield10.2%7.6%4.6%3.8%7.4%3.2%6.0%
Dividend Yield4.1%2.6%0.0%1.4%2.8%0.7%2.0%
FCF Yield 3Y Avg5.4%4.5%3.9%3.0%4.2%3.5%4.1%
D/E0.20.10.10.10.10.10.1
Net D/E0.20.10.10.00.10.10.1

Returns

KMBJNJPGULCLCHDMedian
NameKimberly.Johnson .Procter .Unilever Colgate-.Church &. 
1M Rtn-6.1%7.2%-5.5%-3.0%-5.9%-6.5%-5.7%
3M Rtn-4.3%23.9%-2.3%2.1%-11.1%-8.7%-3.3%
6M Rtn-13.4%26.2%-10.3%-0.2%-15.9%-16.7%-11.9%
12M Rtn-13.1%21.9%-11.3%-0.1%-20.4%-14.7%-12.2%
3Y Rtn18.5%27.1%28.6%56.4%18.0%24.2%25.7%
1M Excs Rtn-4.7%7.1%-5.3%-2.6%-5.0%-5.2%-4.8%
3M Excs Rtn-11.0%10.6%-9.0%-4.1%-16.6%-15.5%-10.0%
6M Excs Rtn-37.0%2.7%-33.6%-23.2%-39.4%-40.0%-35.3%
12M Excs Rtn-26.6%7.8%-24.4%-13.9%-34.2%-27.2%-25.5%
3Y Excs Rtn-60.2%-52.0%-53.1%-26.5%-60.5%-55.2%-54.1%

Comparison Analyses

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date8/1/20254/22/20252/13/202510/22/20247/23/20244/23/20242/8/202410/24/20237/25/20234/25/20232/9/202310/25/2022
Key Financials Quarterly            
Total Revenue4,1634,8404,9284,9524,2315,1494,9705,1325,1345,1954,9645,053
Ebitda8029767601,3487211,033871961269966881829
Operating Income5927695481,251539853670774771787712655
Net Income509567447907544647509587102566507467
EPS1.531.711.342.701.611.921.511.740.301.681.501.38
Key Financials TTM            
Total Revenue TTM18,88318,95119,26019,30219,48220,38520,43120,42520,34620,27520,17520,176
Ebitda TTM3,8863,8053,8623,9733,5863,1343,0673,0772,9453,4633,3763,197
Operating Income TTM3,1603,1073,1913,3132,8363,0683,0023,0442,9252,7752,6812,490
Net Income TTM2,4302,4652,5452,6072,2871,8451,7641,7621,6421,9771,9341,784
Growth Rates Quarterly            
Total Revenue Growth-1.6%-6.0%-0.8%-3.5%-17.6%-0.9%0.1%1.6%1.4%2.0%-0.0%0.9%
EBITDA Growth11.2%-5.5%-12.7%40.3%168.0%6.9%-1.1%15.9%-65.8%9.9%25.5%-1.5%
Operating Income Growth9.8%-9.8%-18.2%61.6%-30.1%8.4%-5.9%18.2%24.2%13.6%36.7%-0.3%
Net Income Growth-6.4%-12.4%-12.2%54.5%433.3%14.3%0.4%25.7%-76.7%8.2%42.0%-0.4%
Margins Quarterly            
EBITDA Margin19.3%20.2%15.4%27.2%17.0%20.1%17.5%18.7%5.2%18.6%17.7%16.4%
Operating Income Margin14.2%15.9%11.1%25.3%12.7%16.6%13.5%15.1%15.0%15.1%14.3%13.0%
Net Income Margin12.2%11.7%9.1%18.3%12.9%12.6%10.2%11.4%2.0%10.9%10.2%9.2%
Cash & Debt            
Total Cash6345631,0211,1111,1638531,093814580524427362
Total Debt7,2417,2477,5747,4517,9647,9708,1148,0908,1358,4818,5498,587
Net Debt / (Cash)6,6076,6846,5536,3406,8017,1177,0217,2767,5557,9578,1228,225
Cash Flows Quarterly            
FCF from Operations7703278179581,0214381,215927787613991798
Cash Flows TTM            
FCF from Operations TTM2,8723,1233,2343,6323,6013,3673,5423,3183,1893,1422,7332,804
Returns to Shareholders Quarterly            
Dividends419405408411411398399399399391391392
Share Repurchases5961248596102541773281302625
Return on Invested Capital (ROIC) Quarterly            
ROIC27.7%35.1%28.5%62.8%27.6%36.6%28.5%33.0%40.8%29.9%27.2%24.7%
Return on Invested Capital (ROIC) TTM            
ROIC TTM37.9%37.6%39.4%41.2%32.6%33.6%33.2%32.8%30.4%26.9%26.0%24.0%

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Baby and Child Care7,0547,166   
Family Care6,2906,243   
Professional3,4043,256   
Adult Care1,8091,730   
Feminine Care1,7871,695   
All Other8785   
Consumer Tissue  6,0346,7185,993
Corporate & Other  676457
Kimberly-Clark (K-C) Professional  3,0723,0193,292
Personal Care  10,2679,3399,108
Total20,43120,17519,44019,14018,450


Price Behavior

KMB Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta0.35-0.21-0.110.170.090.23
Up Beta1.501.120.710.150.100.35
Down Beta0.30-2.94-2.260.11-0.030.05
Up Capture-19%3%3%7%6%5%
Bmk +ve Days13233574144420
Stock +ve Days9202955125400
Down Capture63%-5%32%47%31%45%
Bmk -ve Days8192952107330
Stock -ve Days12223571126350

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date9302025
Short Interest: Shares Quantity8,370,845
Short Interest: % Change Since 915202520.9%
Average Daily Volume2,795,212
Days-to-Cover Short Interest2.99
Basic Shares Quantity332,100,000
Short % of Basic Shares2.5%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
8/1/20254.8%9.7%3.6%
4/22/2025-1.5%-6.5%1.1%
1/28/2025-1.5%-0.7%5.9%
10/22/2024-4.5%-6.0%-6.0%
7/23/2024-5.7%-2.3%0.1%
4/23/20245.5%5.4%3.7%
1/24/2024-5.5%-2.6%-3.1%
10/24/2023-1.1%-1.9%-0.2%
...
SUMMARY STATS   
# Positive11911
# Negative131513
Median Positive2.4%5.4%2.4%
Median Negative-3.4%-2.7%-4.5%
Max Positive8.1%10.8%16.5%
Max Negative-7.0%-10.4%-7.9%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025801202510-Q 6/30/2025
3312025422202510-Q 3/31/2025
12312024213202510-K 12/31/2024
93020241022202410-Q 9/30/2024
6302024723202410-Q 6/30/2024
3312024423202410-Q 3/31/2024
12312023208202410-K 12/31/2023
93020231024202310-Q 9/30/2023
6302023725202310-Q 6/30/2023
3312023425202310-Q 3/31/2023
12312022209202310-K 12/31/2022
93020221025202210-Q 9/30/2022
6302022726202210-Q 6/30/2022
3312022422202210-Q 3/31/2022
12312021210202210-K 12/31/2021
93020211025202110-Q 9/30/2021

Insider Activity

Expand for More

 

External Quote Links


Prefer one of these to Trefis? Tell us why.